Sulfonylureas: Assets in the past, present and future - Wikidata - wikimedia - TriplyDB

Sulfonylureas: Assets in the past, present and future

Sulfonylureas: Assets in the past, present and future

http://www.wikidata.org/entity/Q35197927

about

Progressing From Metformin to Sulfonylureas or Meglitinides.Effects of gliclazide add on metformin on serum omentin-1 levels in patients with type 2 diabetes mellitus.Sulfonylureas: Asset or liability?Modern Sulfonylureas Strike Back - Exploring the Freedom of Flexibility

P2860

Q38952882-1F92BD9C-FE6A-40E8-BDCC-8655370BAA68 Q39005558-2A21386A-554D-4D28-A69A-F316F43B5FA8 Q42402546-B40E6268-4F87-496D-B489-36AC60A65193 Q57822737-9AB196DB-BD85-4A00-B199-21CE37CB2D25

P2860

Sulfonylureas: Assets in the past, present and future

http://www.wikidata.org/entity/Q35197927

description

2015 nî lūn-bûn

@nan

2015 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Sulfonylureas: Assets in the past, present and future

@ast

Sulfonylureas: Assets in the past, present and future

@en

type

label

Sulfonylureas: Assets in the past, present and future

@ast

Sulfonylureas: Assets in the past, present and future

@en

prefLabel

Sulfonylureas: Assets in the past, present and future

@ast

Sulfonylureas: Assets in the past, present and future

@en

P1433

Q35197927-D0818044-A28C-421C-83AF-DDE4B6192C31

P1476

Q35197927-F160121C-3B9D-4FAD-9BB1-BF8889A63C7E

P2093

Q35197927-4B3E43A3-2985-4227-BB8E-F9C512902172

Q35197927-D17020FC-3DE1-4C6D-AD14-B8490CFB524A

P2860

Q35197927-1CB0FCFC-2BEB-4334-B038-C84A72509A89

Q35197927-33AFFA3A-CF39-4D0A-9D14-821EB4A13226

Q35197927-33F780BD-42B2-4238-98F8-D290D498C2BA

Q35197927-37AC1AB1-E63D-48A7-8B78-C0CC807C2443

Q35197927-4B694013-1CEF-4584-9614-0E0A38B8AEDB

Q35197927-8CA2459E-F7A9-4EB4-B50E-E3F68D4D3C14

Q35197927-9348925B-5231-47C2-A8A7-F30EC7671FD2

Q35197927-B0E9234B-CC62-4F7B-86E4-520FE9E888A0

Q35197927-B20847AB-C067-474C-8B18-41131B79F2BE

Q35197927-B4579DB0-F83B-477D-AFF5-233CBE60D077

P304

Q35197927-48A1B82E-B774-4F63-A97A-022443C2C405

P31

Q35197927-0240D1D3-BB1F-4C66-9765-60A7E23FDFD2

Q35197927-5188cf05-c57b-4b7c-9911-78c5f9177988

P356

Q35197927-38A8DC1C-406B-4D04-8B11-06F7455C4F54

P433

Q35197927-21144CA1-604F-4B02-8F31-CB232F783F9F

P478

Q35197927-FD9A12C4-993E-415F-9AE7-44BFD9A82B9E

P50

Q35197927-2D5F398B-A057-4A44-B344-F2C4648C16B3

P577

Q35197927-CCA7AEF2-BCD7-4B9F-84FF-627D452F5CF1

P698

Q35197927-D17D03AA-96EF-4FD5-8E5D-2C9074477F87

P932

Q35197927-F0F7D424-3610-4565-BA75-3B003377AEDB

P356

2230-8210.149925

P1433

Indian Journal of Endocrinology and Metabolism

P1476

Sulfonylureas: Assets in the past, present and future

@en

P2093

S V Madhu

http://www.w3.org/2001/XMLSchema#string

Sarita Bajaj

http://www.w3.org/2001/XMLSchema#string

P2860

Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

Effect of exenatide, sitagliptin, or glimepiride on β-cell secretory capacity in early type 2 diabetes.

Endocrinology and the essential list

Beyond metformin: safety considerations in the decision-making process for selecting a second medication for type 2 diabetes management: reflections from a diabetes care editors' expert forum.

Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report.

Optimal utilisation of sulphonylureas in resource-constrained settings

Sulfonylureas in the treatment of diabetes mellitus--1985.

Improvement of cardio-ankle vascular index by glimepiride in type 2 diabetic patients.

P304

314-316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/2230-8210.149925

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25932384

http://www.w3.org/2001/XMLSchema#string

P932

4366767

http://www.w3.org/2001/XMLSchema#string